This inventor holds 5 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Gw Pharma Limited, Gw Research Limited. Active years: 2017-2020.
Location History:
- Cambridge, GB (2018)
- Histon, GB (2018)
- Salisbury, GB (2017 - 2020)
Company Filing History:
Years Active: 2017-2020
Title: Marnie Duncan: Innovator in Phytocannabinoid Research
Introduction
Marnie Duncan is a notable inventor based in Salisbury, GB. She has made significant contributions to the field of phytocannabinoid research, particularly in the treatment of various cancers. With a total of 5 patents, her work focuses on the therapeutic applications of cannabinoids.
Latest Patents
Marnie Duncan's latest patents include innovative approaches to cancer treatment. One of her notable inventions is the use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of brain tumors. This invention relates to the use of phytocannabinoids to enhance the effectiveness of radiation therapy, particularly for glioma. Another significant patent involves the use of phytocannabinoids in the treatment of ovarian carcinoma. This invention highlights the potential of cannabinoids such as cannabidiol (CBD), cannabigerol (CBG), and others in combination to treat ovarian cancer effectively.
Career Highlights
Throughout her career, Marnie Duncan has worked with prominent companies in the field. She has been associated with Gw Pharma Limited and Gw Research Limited, where she has contributed to groundbreaking research and development in cannabinoid therapies. Her work has garnered attention for its potential to revolutionize cancer treatment.
Collaborations
Marnie has collaborated with esteemed colleagues, including Colin Stott and Farideh Afshin Javid. These collaborations have furthered her research and expanded the impact of her inventions in the medical field.
Conclusion
Marnie Duncan's innovative work in phytocannabinoid research showcases her dedication to improving cancer treatment. Her patents reflect a commitment to exploring the therapeutic potential of cannabinoids, paving the way for future advancements in medicine.